United States: Corp Fin Provides Guidance On New Confidential Treatment Process, Which Is Effective Today

Last Updated: April 4 2019
Article by Cydney Posner

The SEC's new rules related to confidential treatment (part of FAST Act Modernization and Simplification of Regulation S-K) became effective today, April 2, when the adopting release was published in the Federal Register. With that in mind, Corp Fin has posted some guidance under the very descriptive title, New Rules and Procedures for Exhibits Containing Immaterial, Competitively Harmful Information, to help companies comply with the new confidential treatment process, discussed below. The remainder of the release (other than provisions related to data-tagging, which will be phased in) will become effective on May 2. (For a summary of the new rules, see this PubCo post, which, since the intital posting, has been revised and updated.)

New approach. Under the SEC's new approach to confidential treatment, companies will be able to redact information from material contracts without the need to submit in advance formal confidential treatment requests, so long as the redacted information (i) is not material and (ii) would be competitively harmful if publicly disclosed. Under the new rules, contained mostly in Reg S-K Item 601(b), companies will now be required to:

  • "mark the exhibit index to indicate that portions of the exhibit or exhibits have been omitted;
  • include a prominent statement on the first page of the redacted exhibit that certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed; and
  • indicate with brackets where the information has been omitted from the filed version of the exhibit."


It is worth noting here that the adopting release emphasized that the new rules and processes for confidential treatment "do not substantively alter registrant disclosure requirements—they do not affect the principles of what a registrant may or may not permissibly redact from its disclosure for reasons of confidentiality, nor do they change the fundamental disclosure obligations a registrant owes its shareholders under the federal securities laws. Rather, the amendments recognize that the administrative process by which registrants currently are permitted to protect confidential information in certain exhibits is not the most efficient way to serve investors' interests."

Compliance Reviews. Not surprisingly, Corp Fin announces here that it intends to review filings for compliance. When the staff conducts a review in connection with a regular filing review (e.g., review of a periodic report), staff members will separate their "requests for supplemental information, and will request that registrants provide their responses to those requests separately from the regular filing review comment and response process to minimize the risk of inadvertent public disclosure of competitive information."


Why all this attention to separating out all of the materials related to confidential treatment? My understanding is that a critical aspect of the new approach is that the SEC not retain copies of the confidential supplemental material, such as unredacted copies of the material agreements or, if requested by the staff, an analysis supporting the redactions. In general, confidential information retained by the SEC could become publicly available if it is the subject of a valid FOIA request, except to the extent protected by a request for confidential treatment. Accordingly, the company should request that, once the staff has completed its review, all the confidential supplemental material submitted be returned or destroyed, following the procedures of Rule 418 or Rule 12b-4, as applicable. And, because the SEC would not retain unredacted copies or supplemental materials, no CTR would be required for FOIA purposes going forward.

General Compliance Review Process

  • The staff will initiate a redacted exhibit review with a letter request for a paper copy of the unredacted exhibit marked to highlight the redacted information.
  • Upon review, the staff may ask the company to to substantiate the redaction decisions by providing the underlying rationales supplementally.
  • If the staff has no comments, the company will receive a letter indicating that the review is complete.
  • However, if the staff did have questions regarding materiality or competitive harm, the company would receive comments regarding the exhibit separately from any comments on the associated filing.
  • If the staff determined that the supplemental rationales provided by the company did not support the redactions, the staff could request that the exhibit be refiled to disclose additional information.
  • Once questions have been resolved, the company will receive a letter indicating that the review is complete.

Securities Act Registration Statements

  • As in the past, companies will need to resolve any questions relating to redacted exhibits in registration statements before submitting requests for acceleration.
  • The only information that will be publicly posted on EDGAR will be the initial request for an unredacted exhibit and the letter indication the closing of review, both of which will be posted together with the other correspondence related to the filing.
  • The staff will not post staff comments regarding redacted exhibits or company responses, which could contain confidential information.

Exchange Act Filings

  • As with registration statements, only the initial request for an unredacted exhibit and the letter advising that review has been closed for that exhibit will be publicly posted on EDGAR, after the review has been completed.
  • If the review was conducted as part of a regular filing review, the two letters will be posted with the other correspondence related to the filing review.
  • The staff will not post staff comments regarding redacted exhibits or company responses, which could contain confidential information.

Procedures to preserve confidentiality of supplemental materials

  • Companies can request confidential treatment of supplemental materials, such as unredacted copies of agreements or a supplemental analysis of the rationale for the redactions, while in the possession of the staff under Rule 83. (Presumably, the Rule 83 process required here will be a modified version of the process currently used, which does not require submission of justifications for confidential treatment unless a FOIA request is made.)
  • Upon completion of a compliance review, the company should request return or destruction of all supplemental materials by complying with the procedures outlined in Rules 418 or 12b-4, as applicable.
  • Corp Fin will provide specific instructions in the initial request for unredacted exhibits, which should be followed to minimize the risk of inadvertent disclosure: Corp Fin encourages companies "to follow those instructions and not send supplemental responses to requests for unredacted exhibits or other supplemental information relating to those exhibits to individual staff members or the staff member that made the request."

Transition Issues

  • The regular CTR process for requesting confidential treatment pursuant to Rule 406 or Rule 24b-2 remains available.
  • Pending CTR applications under Rule 406 or Rule 24b-2 may be withdrawn if desired.
  • If the CTR is withdrawn, the company will need to refile the exhibit in redacted form in an amended filing that conforms to the amended rules and coordinate the withdrawal with the AD responsible for reviewing the filings.
  • When the AD processes the withdrawal of the CTR, the application and related materials will be destroyed unless the company requests their return.
  • Corp Fin will continue to process new applications for CTR as well as pending applications that have not been withdrawn following established procedures.
  • Existing orders granting confidential treatment that are still in effect will remain in effect until the date stated on the order.


  • Here is an email address for questions: RedactedExhibits@sec.gov.
  • Requests should include the name, phone number and brief summary of the question.


In this statement, SEC Commissioner Robert Jackson voiced his dissent from adoption of the final amendments. One of reasons for his dissent was the "most troubling" decision regarding the confidential treatment process, which, in his view "removes our staff's role as gatekeepers when companies redact information from disclosures—despite evidence that redactions already deprive investors of important information." Historically, Jackson observes, companies work with the staff to agree on permitted redactions:

"There are often good reasons for our staff to permit redactions. But recent research shows that redactions already include information that insiders or the market deems material—showing how important careful review of these requests can be for investors. Today's rule removes both the requirement that firms seek staff review before redacting their filings and the requirement that companies give our staff the materials they intend to redact. The release doesn't grapple with the effects of that decision for the marketplace. But one thing is clear: In a world where redactions already rob the market of information investors need, firms will now feel more free to redact as they wish. And investors, without the assurance that redactions have been reviewed by our staff, will face more uncertainty."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions